NeoMed, Inc. is pleased to announce the first hospital network in the United States has successfully transitioned to NeoMed’s NeoConnect™ family of ENFit products in California. Each facility (including a Children’s Hospital) is “live” using NeoMed’s comprehensive solution including the recently FDA 510(k) cleared Low Dose Tip Syringe for the administration of oral medications and Enteral Feedings in the NICU/PICU. NeoMed’s NeoConnect solution is being used exclusively in each facility.
Since receiving FDA 510(k) clearance in June 2016 for our ENFit® Low Dose Tip design, NeoMed, Inc. has received commitments for immediate conversion from over 60 hospitals nationwide to transition to our NeoConnect Pharmacy and Enteral ENFit solutions. Only NeoMed has both the product availability and experience to support a successful transition to ENFit. Our integrated solution meets both clinical and supply chain requirements.
NeoMed has developed a number of programs designed to help hospitals navigate through this global transition including the “NeoMed Loyalty Program.” This program helps to identify hospital staff training needs, establish and review process protocols, and ensure supply chain integrity before conversion.
NM-WEB-014 Rev 0